Share Those Cell Lines!

In the interview on the following pages, John Maddox raises an issue in the ethics of science about which we need more open discussion in quest of a better articulated consensus. Exactly what is the obligation of scientists to distribute cell lines, virus strains, DNA clones, and other critical research materials? In the physical sciences, one generally expects to be able to follow a published recipe with available materials and achieve the results claimed. In biology, however, it often happe

Written byJoshua Lederberg
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the interview on the following pages, John Maddox raises an issue in the ethics of science about which we need more open discussion in quest of a better articulated consensus. Exactly what is the obligation of scientists to distribute cell lines, virus strains, DNA clones, and other critical research materials?

In the physical sciences, one generally expects to be able to follow a published recipe with available materials and achieve the results claimed. In biology, however, it often happens that a particular cell line or other clone is discovered that has special properties; as a result, no one can expect to retrace all the steps leading to it. The vast majority of cell lines have experienced some idiosyncratic mutations that lend unique qualities to them. In clinical investigation, patients with rare syndromes cannot be distributed or reproduced per se, but specimens from them may be crucial.

Many scientists therefore ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies